Publications for Pia Palmebäck Wegman
Co-author map based on ISI articles 2007-

Journal Articles

Pia Palmebäck Wegman, Nashwan J Marcus, Breezy Paul Malakkaran and Sten Wingren
  Biological significance of allele specific loss of the p53 gene in breast carcinomas
  BREAST CANCER RESEARCH AND TREATMENT, 2009, 118(1), 15-20.
 Web of Science® Times Cited: 4

Pia Wegman Palmebäck, Sauli Elingarami, John Carstensen, Olle Stål, Bo Nordenskjöld and Sten Wingren
  Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal breast cancer patients
  Breast Cancer Research, 2007, 9(1), R7.
   Fulltext  PDF  
 Web of Science® Times Cited: 147

Pia Wegman (Palmebäck), Olle Stål, Marie Stenmark Askmalm, Bo Nordenskjöld, Lars-Erik Rutqvist and Sten Wingren
  p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients
  Pharmacogenetics and Genomics, 2006, 16(5), 347-351.
 Web of Science® Times Cited: 14

Pia Palmebäck Wegman and Sten Wingren
  CYP2D6 variants and the prediction of tamoxifen response in randomized patients: authors' response
  Breast Cancer Research, 2005, 7(6), 234-234.

Malin Bergman, Marie Ahnström, Pia Palmebäck Wegman and Sten Wingren
  Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women
  Journal of Cancer Research and Clinical Oncology, 2005, 131(7), 439-444.
 Web of Science® Times Cited: 26

Pia Wegman (Palmebäck), Linda Vainikka, Olle Stål, Bo Nordenskjöld, Lambert Skoog, Lars-Erik Rutqvist and Sten Wingren
  Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
  Breast Cancer Research, 2005, 7(3), R284-R290.
   Fulltext  PDF  
 Web of Science® Times Cited: 122

Ph.D. Theses

Pia Palmebäck Wegman
  Studies of tamoxifen resistance in breast cancer
  2007.


  Fulltext PDF